<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03964987</url>
  </required_header>
  <id_info>
    <org_study_id>2016-09-481</org_study_id>
    <nct_id>NCT03964987</nct_id>
  </id_info>
  <brief_title>Pancreatic Duodenal Homeobox Factor-1 (PDX-1) and Neurogenin-3 (NGN-3) in Gestational Diabetes</brief_title>
  <official_title>PDX-1 and NGN-3 Expression in Gestational Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Materno-Perinatal Hospital of the State of Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad Autonoma del Estado de Mexico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Materno-Perinatal Hospital of the State of Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: Depletion of the ability of the cells ß to secrete the amount of insulin
      required by pregnancy, increasing the risk of develop Gestational Diabetes Mellitus (GDM).
      The aim was to contrast the messenger RNA (mRNA) expression of the pancreatic duodenal
      homeobox factor-1 (PDX-1) and Neurogenin-3 (Ngn-3) in peripheral blood of pregnant women with
      GDM versus women with normal pregnancies.

      Material and methods: This was a prospective, clinical and cross-sectional study, conforming
      two groups of pregnant women: a) patients with a healthy gestation and b) patients with GDM.
      Besides anthropometry and routine laboratorial test, real-time polymerase chain reaction
      (Real-Time PCR), was used to quantify the expression of PDX-1 and NGN-3.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pregnant women attended in the Maternal-Fetal Medicine Service of the &quot;Mónica Pretelini
      Sáenz&quot; Maternal-Perinatal Hospital, were invited to participate. Those with autoimmune
      diseases, heart disease, nephropathy, liver disease or any other chronic condition were
      excluded and those with incomplete clinical files were discarded from the final analysis. Two
      groups were integrated: a) patients with a healthy gestation and b) patients with GDM.

      From all patients the next information was captured in an excell sheet: weight, height, Body
      Mass Index, blood pressure, albumin, creatinine, electrolytes, glucose, total cholesterol,
      triglycerides, transaminases and relative expression of PDX-1 and NGN-3.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">August 30, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>9 Months</target_duration>
  <primary_outcome>
    <measure>ARNm expression</measure>
    <time_frame>Nine months</time_frame>
    <description>Expression of the genes PDX-1 and NGN-3</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Women with normoevolutionary gestation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Problem group</arm_group_label>
    <description>Patients with GDM.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women attended in the Maternal-Fetal Medicine Service of the HMPMP.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women older than 18 years old.

        Exclusion Criteria:

          -  Those with autoimmune diseases, heart disease, nephropathy, liver disease or any other
             chronic condition.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugo Mendieta Zerón, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maternal-Perinatal Hospital &quot;Mónica Pretelini Sáenz&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Materno-Perinatal Hospital &quot;Mónica Pretelini&quot;</name>
      <address>
        <city>Toluca</city>
        <zip>50130</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Sandikci M, Karagenc L, Yildiz M. Changes on the Pancreas in Experimental Diabetes and the Effect of Lycopene on These Changes: Pdx-1, Ngn-3, and Nestin Expressions. Anat Rec (Hoboken). 2017 Dec;300(12):2200-2207. doi: 10.1002/ar.23687. Epub 2017 Sep 26.</citation>
    <PMID>28921917</PMID>
  </reference>
  <reference>
    <citation>Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development. 2002 May;129(10):2447-57.</citation>
    <PMID>11973276</PMID>
  </reference>
  <results_reference>
    <citation>Wang L, Fan H, Zhou L, Wu Y, Lu H, Luo J. Altered expression of PGC-1α and PDX1 and their methylation status are associated with fetal glucose metabolism in gestational diabetes mellitus. Biochem Biophys Res Commun. 2018 Jun 18;501(1):300-306. doi: 10.1016/j.bbrc.2018.05.010. Epub 2018 May 7.</citation>
    <PMID>29730292</PMID>
  </results_reference>
  <results_reference>
    <citation>Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018 Oct 26;19(11). pii: E3342. doi: 10.3390/ijms19113342. Review.</citation>
    <PMID>30373146</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 21, 2019</study_first_submitted>
  <study_first_submitted_qc>May 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2019</study_first_posted>
  <last_update_submitted>May 24, 2019</last_update_submitted>
  <last_update_submitted_qc>May 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Materno-Perinatal Hospital of the State of Mexico</investigator_affiliation>
    <investigator_full_name>Hugo Mendieta Zeron</investigator_full_name>
    <investigator_title>Chief of the Research Department</investigator_title>
  </responsible_party>
  <keyword>PDX-1</keyword>
  <keyword>NGN-3</keyword>
  <keyword>Glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Information will be available upon request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

